# A Study to Compare Two Dosing Regimens for a New Malaria Vaccine

> **NCT06141057** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **University of Oxford** · enrollment: 24 (estimated)

## Conditions studied

- Malaria
- Malaria,Falciparum
- Protozoan Infections
- Parasitic Disease
- Infections
- Vector Borne Diseases

## Interventions

- **BIOLOGICAL:** Matrix M with RH5.1

## Key facts

- **NCT ID:** NCT06141057
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-06
- **Primary completion:** 2025-07
- **Final completion:** 2025-07
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2024-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06141057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06141057, "A Study to Compare Two Dosing Regimens for a New Malaria Vaccine". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06141057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*